Product Images Paclitaxel Paclitaxel

This is a description of a medication called Paclitaxel Injection, USP. It is manufactured by Gland Pharma in India and comes in vials with a concentration of 30 mg/5 mL or 6 mg/mL. The medication is a cytotoxic agent and multiple doses are provided in each vial. It is important to dilute the medication prior to IV infusion and to store the vials between 20° to 25°C. The text also includes instructions to protect the medication from light and retain it in the carton until it is time to be used. Additionally, gloves should be worn when handling the containers. Further dosage information can be found in the insert.*

This is a description of a medication called Paclitaxel Injection, USP. The medication is manufactured by Gland Pharma Limited in India and is a cytotoxic agent stored in a sterile multiple-dose vial. The vial contains 100 mg/16.7 mL with a concentration of 6 mg/mL. The dosage and directions for use are provided in the insert, and precautions must be taken when handling and storing the vials. Dilution is also required prior to IV infusion. The NDC number for the medication is 68083-175.01.*

This text describes a medication called Paclitaxel Injection, available in 50 mL vials that must be stored at controlled room temperature and protected from light. The dosage is given in the information for the medication's insert, and directions for use and precautions are included. The medication is manufactured by Gland Pharma Limited in India, and it is a cytotoxic agent that requires dilution prior to IV infusion. The vials contain 6 mg/mL of Paclitaxel USP, in a solution with Polyoxyl 35 Castor Oil NF, Dehydrated Alcohol, USP, and Citric Acid, USP. The dosage mentioned is "Usual Dosage: 50 x 40 mm".*

This is a survival analysis plot displaying the proportion of individuals surviving at different time intervals. The x-axis represents time in years and the y-axis represents the proportion surviving. The numbers on the plot give the number of individuals at risk at each time point. The HR (95% C) of 0.73 (0.60-0.89) suggests a statistically significant difference in survival between two groups. No further information is available.*

This text represents statistical data analysis. It shows the proportion surviving along with the number of events, hazard ratio, and confidence intervals. It also provides the number at risk for each year of the study.*

This appears to be a survival analysis table, showing data on the proportion of individuals surviving at different time points. It includes information on the number of events (deaths or other outcomes), as well as confidence intervals and the number of individuals at risk at each time point. However, without more context or information about the specific study or dataset, it is not possible to provide a more detailed description of the findings.*

This appears to be a statistical analysis of disease-free proportions, possibly related to a medical study. The HR (hazard ratio) is given as 0.73 with a confidence interval of 0.57-0.93, and the number of events and participants is listed for two treatments (AC+T and AC). It is unclear what the "No. events" and "Number at Risk" numbers refer to without more context.*